Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review. [PDF]
Pharmaceuticals (Basel)Dumitru CN +6 more
europepmc +1 more source
Genotype influences antidepressant discontinuation in a pre-emptive pharmacogenetic testing population. [PDF]
Pharmacogenomics JBaye JF +7 more
europepmc +1 more source
Response: Codeine in Breast Milk: Minimal Transfer, Still Risky for Neonates. [PDF]
Paediatr AnaesthAnderson BJ, Hannam JA.
europepmc +1 more source
CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study. [PDF]
Pharmaceuticals (Basel)Oskay A +12 more
europepmc +1 more source
CYP2E1 and CYP2D6 in Anti-Tuberculosis Drug-Induced Liver Injury: Mechanisms, Epigenetic Regulation, and Translational Implications. [PDF]
Clin Transl SciPrakongsup P, Udomsinprasert W.
europepmc +1 more source
Correction to "Impact of CYP2D6 Genotype and Inhibitor Use on Risperidone Metabolism in Children: Functional Insights Into the *17 and *29 Alleles". [PDF]
Clin Transl Scieuropepmc +1 more source
The Impact of the CYP2D6 “Enhancer” Single Nucleotide Polymorphism on CYP2D6 Activity
Clinical Pharmacology & Therapeutics, 2021 rs5758550 has been associated with enhanced transcription and suggested to be a useful marker of CYP2D6 activity. As there are limited and inconsistent data regarding the utility of this distant “enhancer” single nucleotide polymorphism (SNP), our goal was to further assess the impact of rs5758550 on CYP2D6 activity toward two probe substrates ...
Jean C, Dinh +7 more
openaire +3 more sources